Grufity logoGrufity logo

Cerner Corp Stock Research

CERN

Market Closed

CERN Stock Price

CERN RSI Chart

CERN Valuation

Market Cap

27.9B

Price/Earnings (Trailing)

47.36

Price/Sales (Trailing)

4.81

EV/EBITDA

19.86

Price/Free Cashflow

19.38

CERN Price/Sales (Trailing)

CERN Profitability

Free Cashflow Yield

5.16%

CERN Fundamentals

CERN Revenue

CERN Earnings

Price Action

Last 7 days

0.1%

Last 30 days

1.0%

Last 90 days

2.3%

Trailing 12 Months

20.8%

CERN Financial Health

CERN Investor Care

Peers (Alternatives to Cerner)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
439.0B
324.2B
-0.88% -8.54%
21.82
1.35
12.71% 16.40%
27.9B
-
0.98% 20.75%
47.36
4.81
- -
27.8B
2.1B
8.14% -16.29%
70.25
13.4
17.88% -8.53%
MID-CAP
9.0B
3.5B
11.88% 31.28%
-116.8
2.57
7.15% -34.72%
4.0B
2.4B
-7.78% -66.57%
-0.29
1.65
18.41% -3085.58%
2.5B
1.3B
3.53% -57.31%
446.52
1.95
14.48% -92.74%
SMALL-CAP
1.6B
262.3M
-16.17% 5.00%
-8.79
6.19
33.16% -131.28%
1.4B
837.2M
-22.28% -42.42%
23.26
1.68
3.88% -92.18%
1.1B
625.9M
-5.47% -18.51%
49.3
1.81
6.21% 3223.77%
885.1M
53.5M
14.54% -12.33%
82.7
16.56
10.94% 3.61%
804.5M
2.8B
-16.22% 4.04%
4.27
0.29
67.39% 42.77%
800.9M
266.8M
2.11% 29.65%
66.24
3
3.94% 106.86%
628.9M
276.2M
-18.48% -57.25%
-4.58
2.28
14.18% 10.32%
429.9M
317.4M
-0.27% -12.77%
22.93
1.35
16.07% 16.08%

Financials for Cerner

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q12021Q42021Q32021Q22021Q1
Revenue0.7%5,8075,7655,7085,6085,482
  S&GA Expenses-0.6%518521491486464
Costs and Expenses0.2%5,0655,0575,0414,9724,748
EBITDA2.3%1,4511,418---
EBITDA Margin1.6%0.25*0.25*---
Earnings Before Taxes4.7%7326996639031,027
EBT Margin3.9%0.13*0.12*---
Net Income6.1%589556522703805
Net Income Margin5.3%0.10*0.10*---
Free Cahsflow-2.8%1,4401,482---
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q12021Q42021Q32021Q22021Q1
Assets-0.8%7,3747,4347,5437,7217,908
  Current Assets0.8%2,4682,4492,4402,5413,055
    Cash Equivalents20.3%710590460246998
  Inventory-1.6%28.0028.0025.0020.0030.00
  Net PPE-2.8%1,6101,6561,7181,7691,803
  Goodwill-0.1%1,1301,1311,1271,130912
Liabilities-7.7%3,4663,7543,7033,6953,596
  Current Liabilities-15.2%1,3791,6261,5511,5431,463
    LT Debt, Current-100.0%-225225225225
    LT Debt, Non Current0.0%1,6111,6111,6111,6111,611
Shareholder's Equity6.2%3,9093,6803,8404,0264,312
  Retained Earnings1.9%6,8776,7526,6576,5476,581
  Additional Paid-In Capital3.5%2,8122,7172,5992,5102,368
Accumulated Depreciation-1,934----
Shares Outstanding-0.9%293296301305-
Float-20,900----
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q12021Q42021Q32021Q22021Q1
Cashflow From Operations-4.3%1,6961,7721,7671,7141,604
  Share Based Compensation-7.2%182196201183167
Cashflow From Investing23.3%-559-729-909-1,327-846
Cashflow From Financing-34.0%-1,413-1,054-809-414-48.42
  Dividend Payments4.4%279267257246233
  Buy Backs-22.8%1,1581,5001,232857449

Risks for CERN

What is the probability of a big loss on CERN?

56.1%


Probability that Cerner stock will be more than 20% underwater in next one year

1.1%


Probability that Cerner stock will be more than 30% underwater in next one year.

0%


Probability that Cerner stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CERN drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Cerner was unfortunately bought at previous high price.

Drawdowns

Returns for CERN

Cumulative Returns on CERN

9.5%


10-Year Cumulative Returns

5.9%


7-Year Cumulative Returns

7.6%


5-Year Cumulative Returns

10.5%


3-Year Cumulative Returns

What are the long-term rolling returns for CERN?

FIve years rolling returns for Cerner.

Annualized Returns

Which funds bought or sold CERN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-02-09
HUNTINGTON NATIONAL BANK
unchanged
-
95.00
95.00
-%
2023-02-07
IFP Advisors, Inc
sold off
-100
-549,000
-
-%
2022-08-15
Frontier Wealth Management LLC
sold off
-100
-757,000
-
-%
2022-07-28
Private Capital Group, LLC
sold off
-100
-31,000
-
-%
2022-07-20
IBM Retirement Fund
sold off
-100
-441,000
-
-%
2022-05-31
Mid-American Wealth Advisory Group, Inc.
reduced
-0.56
-
330,000
0.26%
2022-05-23
SPRING CREEK CAPITAL LLC
new
-
65,492,000
65,492,000
2.59%
2022-05-16
Parametric Portfolio Associates LLC
added
7.55
9,646,000
125,134,000
0.07%
2022-05-16
Amalgamated Financial Corp.
new
-
7,659,000
7,659,000
0.06%
2022-05-16
Tibra Equities Europe Ltd
new
-
21,185,000
21,185,000
23.44%

1–10 of 47

Latest Funds Activity

Are funds buying CERN calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own CERN
No. of Funds

Cerner News

StockNews.com

ORCL: 1 Software Stock That's an Exceptional Long-Term Buy.

StockNews.com,
18 days ago

StockNews.com

StockNews.com

The Motley Fool

The Business Journals

Yahoo Finance

Yahoo Finance

Oracle Completes Acquisition of Cerner.

Yahoo Finance,
9 months ago

Schedule 13G FIlings of Cerner

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2022
vanguard group inc
10.81%
31,586,238
SC 13G/A
Feb 07, 2022
blackrock inc.
8.3%
24,425,920
SC 13G/A
Mar 10, 2021
bank of new york mellon corp
3.18%
9,742,229
SC 13G/A
Feb 10, 2021
vanguard group inc
10.65%
32,645,742
SC 13G/A
Feb 01, 2021
bank of new york mellon corp
5.21%
15,965,148
SC 13G
Jan 29, 2021
blackrock inc.
8.2%
25,096,524
SC 13G/A
Feb 12, 2020
vanguard group inc
10.65%
33,451,876
SC 13G/A
Feb 05, 2020
blackrock inc.
7.5%
23,516,312
SC 13G/A

CERN Fair Value

Latest Insider Trading transactions for CERN

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-06-08
WISE R HALSEY
back to issuer
-302,860
95.00
-3,188
-
2022-06-08
Granger Elder
back to issuer
-513,285
95.00
-5,403
-
2022-06-08
Battaglioli Michael R.
back to issuer
-324,140
95.00
-3,412
svp & chief accounting officer
2022-06-08
ZOLLARS WILLIAM D
back to issuer
-349,600
95.00
-3,680
-
2022-06-07
Labat Jerome
sold
-2,081,360
95.00
-21,909
evp & chief technology officer
2022-06-07
Dalton Travis
sold
-43,130
95.00
-454
evp & chief client & serv. off
2022-06-07
Labat Jerome
sold
-3,515
95.00
-37.00
evp & chief technology officer
2022-06-07
Dalton Travis
sold
-51,205
95.00
-539
evp & chief client & serv. off
2022-06-07
Daniels Mitchell E
sold
-3,558,700
95.00
-37,460
-
2022-06-07
Erceg Mark J
sold
-4,170,980
95.00
-43,905
exec. vp & cfo

1–10 of 50

David T. Feinberg
25200
Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. It offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers. The company also provides HealtheIntent platform, a cloud-based platform to aggregate, transform, and reconcile data across the continuum of care; and CareAware, an EHR agnostic platform that facilitates connectivity of health care devices to EHRs. In addition, it offers a portfolio of clinical and financial healthcare information technology solutions, as well as departmental and care coordination solutions. Further, the company provides tech-enabled services, such as implementation and training, remote hosting, application management, revenue cycle, support and maintenance, health care data analysis, real-world evidence, clinical process optimization, transaction processing, employer health centers, and data-driven services; and complementary hardware and devices for third parties. It serves integrated delivery networks, physician groups and networks, managed care organizations, hospitals, medical centers, free-standing reference laboratories, home health agencies, blood banks, imaging centers, pharmacies, pharmaceutical manufacturers, employers, governments, and public health organizations. The company was founded in 1979 and is headquartered in North Kansas City, Missouri.

CERN Income Statement

2022-03-31
Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues$ 1,429,801$ 1,387,778
Costs and expenses:  
Costs of revenue243,848230,656
Sales and client service612,997622,176
Software development (Includes amortization of $65,206 and $64,850, respectively)195,091192,327
General and administrative109,279112,365
Amortization of acquisition-related intangibles16,60212,196
Total costs and expenses1,177,8171,169,720
Operating earnings251,984218,058
Other income, net261,206
Earnings before income taxes252,010219,264
Income taxes(45,881)(47,012)
Net earnings$ 206,129$ 172,252
Basic earnings per share$ 0.70$ 0.57
Diluted earnings per share$ 0.70$ 0.56
Basic weighted average shares outstanding293,412304,731
Diluted weighted average shares outstanding296,336308,031

CERN Balance Sheet

2022-03-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 709,532$ 589,847
Short-term investments171,180252,622
Receivables, net1,178,0371,161,361
Inventory27,70428,159
Prepaid expenses and other381,404417,465
Total current assets2,467,8572,449,454
Property and equipment, net1,610,4961,656,171
Right-of-use assets76,47482,940
Software development costs, net1,003,8061,000,357
Goodwill1,129,5391,131,121
Intangible assets, net434,900458,482
Long-term investments456,398461,984
Other assets194,761193,649
Total assets7,374,2317,434,158
Current liabilities:  
Accounts payable359,562329,582
Current installments of long-term debt0225,000
Deferred revenue456,929531,234
Accrued payroll and tax withholdings284,145317,092
Other current liabilities278,236223,350
Total current liabilities1,378,8721,626,258
Long-term Debt1,611,3031,611,256
Deferred income taxes362,236395,177
Other liabilities113,301121,005
Total liabilities3,465,7123,753,696
Shareholders' Equity:  
Common stock, $0.01 par value, 500,000,000 shares authorized, 381,357,862 shares issued at March 31, 2022 and 380,232,975 shares issued at December 31, 20213,8143,802
Additional paid-in capital2,811,6122,717,244
Retained earnings6,877,1116,751,692
Treasury stock, 87,383,166 shares at March 31, 2022 and December 31, 2021(5,664,718)(5,664,718)
Accumulated other comprehensive loss, net(119,300)(127,558)
Total shareholders' equity3,908,5193,680,462
Total liabilities and shareholders' equity$ 7,374,231$ 7,434,158
Common stock, par value$ 0.01 
Common Stock, Shares Authorized500,000,000 
Common stock, shares issued381,357,862380,232,975
Treasury Stock, Shares87,383,166